Virgin Money UK PLC Publication of Final Terms (5310Y)
September 09 2020 - 10:55AM
UK Regulatory
TIDMVMUK TIDM91XR
RNS Number : 5310Y
Virgin Money UK PLC
09 September 2020
VIRGIN MONEY UK PLC
(Company)
LEI: 213800ZK9VGCYYR6O495
9 September 2020
Publication of Final Terms
The following final terms (the "Final Terms") are available for
viewing:
Final Terms dated 9 September 2020 relating to the Series 6
GBP475,000,000 5.125 per cent. Fixed Rate Reset Callable
Subordinated Tier 2 Capital Notes due 2030 issued by the Company
under the GBP10,000,000,000 Global Medium Term Note Programme of
the Company and Clydesdale Bank PLC
Please read the disclaimer below "Disclaimer - Intended
Addressees" before attempting to access this service, as your right
to do so is conditional upon complying with the requirements set
out below.
To view the full document, please paste the following URL into
the address bar of your browser.
http://www.rns-pdf.londonstockexchange.com/rns/5310Y_1-2020-9-9.pdf
A copy of the above document has been submitted to the National
Storage Mechanism and will shortly be available for inspection at:
https://data.fca.org.uk/#/nsm/nationalstoragemechanism .
Announcement authorised for release by Lorna McMillan, Group
Company Secretary.
Enquiries
Investors and Analysts
Andrew Downey +44 203 216 2694
------------------------------------
Head of Investor Relations +44 7823 443150
------------------------------------
andrew.downey@virginmoneyukplc.com
------------------------------------
Company Secretary
------------------------------------
Lorna McMillan + 44 7834 585436
------------------------------------
Group Company Secretary lorna.mcmillan@virginmoneyukplc.com
------------------------------------
Media Relations
------------------------------------
Press Office 0800 066 5998
------------------------------------
press.office@virginmoneyukplc.com
------------------------------------
DISCLAIMER - INTENDED ADDRESSEES
IMPORTANT: You must read the following before continuing: The
following applies to the Final Terms available by clicking on the
link above, and you are therefore advised to read this carefully
before reading, accessing or making any other use of the Final
Terms. In accessing the Final Terms, you agree to be bound by the
following terms and conditions, including any modifications to
them, any time you receive any information from us as a result of
such access.
The Final Terms must be read in conjunction with the base
prospectus dated 5 February 2020 relating to the GBP10,000,000,000
Global Medium Term Note Programme of the Company and Clydesdale
Bank PLC, as supplemented by the supplemental prospectuses dated 13
May 2020 and 28 August 2020 (the "Base Prospectus"), which
comprises a prospectus for the purposes of the Prospectus
Regulation (Regulation (EU) 2017/1129).
THE FINAL TERMS MAY NOT BE FORWARDED OR DISTRIBUTED OTHER THAN
AS PROVIDED BELOW AND MAY NOT BE REPRODUCED IN ANY MANNER
WHATSOEVER. THE FINAL TERMS MAY ONLY BE DISTRIBUTED OUTSIDE THE
UNITED STATES TO PERSONS THAT ARE NOT U.S. PERSONS AS DEFINED IN,
AND IN RELIANCE ON, REGULATION S UNDER THE U.S. SECURITIES ACT OF
1933, AS AMENDED (THE "SECURITIES ACT"). ANY FORWARDING,
DISTRIBUTION OR REPRODUCTION OF THE FINAL TERMS IN WHOLE OR IN PART
IS PROHIBITED. FAILURE TO COMPLY WITH THIS NOTICE MAY RESULT IN A
VIOLATION OF THE SECURITIES ACT OR THE APPLICABLE LAWS OF OTHER
JURISDICTIONS.
NOTHING IN THIS ELECTRONIC PUBLICATION CONSTITUTES AN OFFER OF
SECURITIES FOR SALE IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO DO
SO.
Please note that the information contained in the Final Terms
and the Base Prospectus may be addressed to and/or targeted at
persons who are residents of particular countries (specified in the
Base Prospectus) only and is not intended for use and should not be
relied upon by any person outside these countries and/or to whom
the offer contained in the Final Terms and the Base Prospectus is
not addressed. Prior to relying on the information contained in the
Final Terms and the Base Prospectus you must ascertain from the
Final Terms and the Base Prospectus (as applicable) whether or not
you are part of the intended addressees of the information
contained therein.
Confirmation of your Representation: In order to be eligible to
view the Final Terms or make an investment decision with respect to
these Notes, you must be a person other than a U.S. person (within
the meaning of Regulation S under the Securities Act). By accessing
the Final Terms you shall be deemed to have represented that you
and any customers you represent are not a U.S. person (as defined
in Regulation S to the Securities Act) and that you consent to
delivery of the Final Terms via electronic publication.
You are reminded that the Final Terms have been made available
to you on the basis that you are a person into whose possession the
Final Terms may be lawfully delivered in accordance with the laws
of the jurisdiction in which you are located and you may not, nor
are you authorised to, deliver the Final Terms to any other
person.
The Final Terms and the Base Prospectus do not constitute, and
may not be used in connection with, an offer or solicitation in any
place where offers or solicitations are not permitted by law. If a
jurisdiction requires that the offering be made by a licensed
broker or dealer and the underwriters or any affiliate of the
underwriters is a licensed broker or dealer in that jurisdiction,
the offering shall be deemed to be made by the underwriters or such
affiliate on behalf of the Company in such jurisdiction. Under no
circumstances shall the Final Terms or the Base Prospectus
constitute an offer to sell, or the solicitation of an offer to
buy, nor shall there be any sale of any Notes issued or to be
issued pursuant to the Final Terms or the Base Prospectus, in any
jurisdiction in which such offer, solicitation or sale would be
unlawful.
The Final Terms have been made available to you in an electronic
form. You are reminded that documents transmitted via this medium
may be altered or changed during the process of electronic
transmission and consequently none of the Company, its advisers or
any person who controls the Company or any director, officer,
employee or agent of the Company or affiliate of any such person
accepts any liability or responsibility whatsoever in respect of
any difference between the Final Terms made available to you in
electronic format and the hard copy version available to you on
request from the Company.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
PFTEKLFBBKLEBBL
(END) Dow Jones Newswires
September 09, 2020 11:55 ET (15:55 GMT)
Ve Bionic Etf (LSE:CYBG)
Historical Stock Chart
From Apr 2024 to May 2024
Ve Bionic Etf (LSE:CYBG)
Historical Stock Chart
From May 2023 to May 2024